Understanding how immune cells affect kidney disease in Tuberous Sclerosis Complex
Mechanisms of immunosuppression in the development and progression of renal disease in Tuberous Sclerosis Complex
This study is looking at how certain immune cells might be affecting kidney problems in people with Tuberous Sclerosis Complex, and it aims to find new ways to help improve kidney health for those living with this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11101408 on NIH RePORTER |
What this research studies
This research investigates the role of specific immune cells, particularly immunosuppressive macrophages, in the development and progression of kidney disease associated with Tuberous Sclerosis Complex (TSC). The study aims to uncover how these immune cells and a molecule called B7-H3 contribute to kidney problems in TSC patients. By examining tissue samples and conducting experiments, researchers hope to identify potential therapeutic targets that could improve kidney health in affected individuals. The ultimate goal is to develop new treatment strategies that could enhance immune function and reduce kidney disease severity.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Tuberous Sclerosis Complex who are experiencing renal disease, such as angiomyolipomas or cysts.
Not a fit: Patients without Tuberous Sclerosis Complex or those not experiencing renal complications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that improve kidney health and overall outcomes for patients with Tuberous Sclerosis Complex.
How similar studies have performed: Previous research has shown promising results in targeting immune mechanisms in other diseases, suggesting potential for success in this novel approach.
Where this research is happening
Boston, United States
- Brigham and Women's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Henske, Elizabeth P — Brigham and Women's Hospital
- Study coordinator: Henske, Elizabeth P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.